Research Keyword: preclinical model

Psilocybin During the Postpartum Period Induces Long-Lasting Adverse Effects in Both Mothers and Offspring

A new study shows that psilocybin, a psychedelic compound being tested for postpartum depression, may actually cause harm during the breastfeeding period. While the drug helped non-pregnant mice feel less anxious, it made postpartum mothers more anxious and worsened their caregiving behaviors. Even more concerning, baby mice exposed to psilocybin through breast milk developed mood and social problems as adults, suggesting potential lasting risks for human infants.

Read More »

Investigating the Potential of Psilocybin for Compulsive Eating in a Rat Model of Binge Eating

Researchers tested whether psilocybin, a psychedelic compound from magic mushrooms, could help reduce compulsive eating in rats bred to binge eat high-fat, high-sugar foods. Using a fear-conditioning experiment, they found that a single dose of psilocybin did not reduce the rats’ compulsive eating behavior at the dosage tested. However, the treatment may have affected fear-related freezing responses, suggesting psilocybin might influence brain circuits involved in learning and memory.

Read More »
Scroll to Top